EGFR and non-small cell lung carcinoma: Although our analysis focused on combinations involving bevacizumab, other chemotherapy regimens—such as pemetrexed plus cisplatin or carboplatin—have shown efficacy in EGFR-mutant NSCLC when combined with EGFR-TKIs in selected clinical trials [32,33].